| - GRCh37:
- Chr17:16843828
- GRCh38:
- Chr17:16940514
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Uncertain significance (Jun 15, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842861-19578885
| ALDH3A2, ALKBH5, ATPAF2, B9D1, COPS3, DRC3, DRG2, EPN2, EVPLL, FAM83G, FBXW10, FLCN, FLII, GID4, GRAP, GRAPL, LGALS9C, LLGL1, MAPK7, MED9, MFAP4, MIEF2, MIR33B, MPRIP, MYO15A, NT5M, PEMT, PLD6, PRPSAP2, RAI1, RASD1, RNF112, SHMT1, SLC47A1, SLC5A10, SMCR8, SNORD3A, SREBF1, TBC1D28, TNFRSF13B, TOM1L2, TOP3A, TRIM16L, TVP23B | | Familial aplasia of the vermis, Meckel-Gruber syndrome, Immunodeficiency, common variable, 2
| Uncertain significance (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842861-16843845
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Uncertain significance (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875309-16875389
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Pathogenic (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843124
- GRCh38:
- Chr17:16939810
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843818
- GRCh38:
- Chr17:16940504
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Uncertain significance (Jan 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855748
- GRCh38:
- Chr17:16952434
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843076
- GRCh38:
- Chr17:16939762
| TNFRSF13B | S223T | Immunodeficiency, common variable, 2 | Uncertain significance (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843010
- GRCh38:
- Chr17:16939696
| TNFRSF13B | A245T | Immunodeficiency, common variable, 2 | Uncertain significance (May 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852296
- GRCh38:
- Chr17:16948982
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842979
- GRCh38:
- Chr17:16939665
| TNFRSF13B | C255Y | Immunodeficiency, common variable, 2, TNFRSF13B-related condition | Uncertain significance (May 16, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:16875335
- GRCh38:
- Chr17:16972021
| TNFRSF13B | E19K | Immunodeficiency, common variable, 2 | Uncertain significance (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855810
- GRCh38:
- Chr17:16952496
| TNFRSF13B | C50S | Immunodeficiency, common variable, 2 | Uncertain significance (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843041
- GRCh38:
- Chr17:16939727
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875350
- GRCh38:
- Chr17:16972036
| TNFRSF13B | R14G | Immunodeficiency, common variable, 2 | Uncertain significance (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842990
- GRCh38:
- Chr17:16939676
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Oct 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842903
- GRCh38:
- Chr17:16939589
| TNFRSF13B | I281fs | Immunodeficiency, common variable, 2 | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843011
- GRCh38:
- Chr17:16939697
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842887
- GRCh38:
- Chr17:16939573
| TNFRSF13B | A286T | Immunodeficiency, common variable, 2 | Uncertain significance (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843640
- GRCh38:
- Chr17:16940326
| TNFRSF13B | D211N | Immunodeficiency, common variable, 2 | Uncertain significance (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852072
- GRCh38:
- Chr17:16948758
| TNFRSF13B | R142T | Immunodeficiency, common variable, 2 | Uncertain significance (Oct 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843778
- GRCh38:
- Chr17:16940464
| TNFRSF13B | S165G | Immunodeficiency, common variable, 2 | Uncertain significance (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875348
- GRCh38:
- Chr17:16972034
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843066
- GRCh38:
- Chr17:16939752
| TNFRSF13B | P226R | Immunodeficiency, common variable, 2 | Uncertain significance (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875372
- GRCh38:
- Chr17:16972058
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855755
- GRCh38:
- Chr17:16952441
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852064
- GRCh38:
- Chr17:16948750
| TNFRSF13B | E145K | Immunodeficiency, common variable, 2 | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855752
- GRCh38:
- Chr17:16952438
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843108
- GRCh38:
- Chr17:16939794
| TNFRSF13B | H212P | Immunodeficiency, common variable, 2 | Uncertain significance (Aug 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875322
- GRCh38:
- Chr17:16972008
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Dec 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855868
- GRCh38:
- Chr17:16952554
| TNFRSF13B | M31V | Immunodeficiency, common variable, 2 | Uncertain significance (Feb 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855863
- GRCh38:
- Chr17:16952549
| TNFRSF13B | R32S | Immunodeficiency, common variable, 2 | Uncertain significance (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852140
- GRCh38:
- Chr17:16948826
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842930
- GRCh38:
- Chr17:16939616
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852194
- GRCh38:
- Chr17:16948880
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843021
- GRCh38:
- Chr17:16939707
| TNFRSF13B | T241K | Immunodeficiency, common variable, 2 | Uncertain significance (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842878
- GRCh38:
- Chr17:16939564
| TNFRSF13B | G289R | Immunodeficiency, common variable, 2 | Uncertain significance (May 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852106
- GRCh38:
- Chr17:16948792
| TNFRSF13B | D131N | Immunodeficiency, common variable, 2 | Uncertain significance (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843716
- GRCh38:
- Chr17:16940402
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855857
- GRCh38:
- Chr17:16952543
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (May 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843656
- GRCh38:
- Chr17:16940342
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Dec 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855813
- GRCh38:
- Chr17:16952499
| TNFRSF13B | S49F | Immunodeficiency, common variable, 2 | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852191
- GRCh38:
- Chr17:16948877
| TNFRSF13B | Y102* | Immunodeficiency, common variable, 2 | Pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855818
- GRCh38:
- Chr17:16952504
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852069
- GRCh38:
- Chr17:16948755
| TNFRSF13B | G143D | Immunodeficiency, common variable, 2 | Uncertain significance (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842965
- GRCh38:
- Chr17:16939651
| TNFRSF13B | G260R | Immunodeficiency, common variable, 2 | Uncertain significance (Feb 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855828
- GRCh38:
- Chr17:16952514
| TNFRSF13B | L44P | Immunodeficiency, common variable, 2 | Uncertain significance (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852060
- GRCh38:
- Chr17:16948746
| TNFRSF13B | A146V | Immunodeficiency, common variable, 2 | Uncertain significance (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852042
- GRCh38:
- Chr17:16948728
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Sep 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852188
- GRCh38:
- Chr17:16948874
| TNFRSF13B | F103L | Immunodeficiency, common variable, 2 | Uncertain significance (Jun 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843773
- GRCh38:
- Chr17:16940459
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843723
- GRCh38:
- Chr17:16940409
| TNFRSF13B | A183G | Immunodeficiency, common variable, 2 | Uncertain significance (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842932
- GRCh38:
- Chr17:16939618
| TNFRSF13B | C271R | Immunodeficiency, common variable, 2 | Uncertain significance (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842955
- GRCh38:
- Chr17:16939641
| TNFRSF13B | T263I | Immunodeficiency, common variable, 2 | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852231
- GRCh38:
- Chr17:16948917
| TNFRSF13B | C89Y | Immunodeficiency, common variable, 2, not provided | Uncertain significance (May 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:16842999
- GRCh38:
- Chr17:16939685
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855884
- GRCh38:
- Chr17:16952570
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843845
- GRCh38:
- Chr17:16940531
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855906
- GRCh38:
- Chr17:16952592
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852290
- GRCh38:
- Chr17:16948976
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (May 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843020
- GRCh38:
- Chr17:16939706
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Apr 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852170
- GRCh38:
- Chr17:16948856
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (May 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842873
- GRCh38:
- Chr17:16939559
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Dec 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843806
- GRCh38:
- Chr17:16940492
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Dec 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843701
- GRCh38:
- Chr17:16940387
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875318
- GRCh38:
- Chr17:16972004
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843782
- GRCh38:
- Chr17:16940468
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843121
- GRCh38:
- Chr17:16939807
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Apr 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875318
- GRCh38:
- Chr17:16972004
| TNFRSF13B | | not specified, Immunodeficiency, common variable, 2 | Benign/Likely benign (May 19, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:16842969
- GRCh38:
- Chr17:16939655
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Mar 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852304
- GRCh38:
- Chr17:16948990
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843787
- GRCh38:
- Chr17:16940473
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843630
- GRCh38:
- Chr17:16940316
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852266
- GRCh38:
- Chr17:16948952
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842886-16842901
- GRCh38:
- Chr17:16939572-16939587
| TNFRSF13B | I281fs | Immunodeficiency, common variable, 2 | Uncertain significance (Mar 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875330
- GRCh38:
- Chr17:16972016
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Uncertain significance (Sep 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855838
- GRCh38:
- Chr17:16952524
| TNFRSF13B | D41N | Immunodeficiency, common variable, 2 | Uncertain significance (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843804
- GRCh38:
- Chr17:16940490
| TNFRSF13B | S156N | Immunodeficiency, common variable, 2 | Uncertain significance (Mar 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16842956
- GRCh38:
- Chr17:16939642
| TNFRSF13B | T263A | Immunodeficiency, common variable, 2 | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852282
- GRCh38:
- Chr17:16948968
| TNFRSF13B | R72L | Immunodeficiency, common variable, 2 | Uncertain significance (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852234
- GRCh38:
- Chr17:16948920
| TNFRSF13B | S88N | Immunodeficiency, common variable, 2 | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852048
- GRCh38:
- Chr17:16948734
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Uncertain significance (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852256
- GRCh38:
- Chr17:16948942
| TNFRSF13B | H81N | Immunodeficiency, common variable, 2 | Uncertain significance (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843706
- GRCh38:
- Chr17:16940392
| TNFRSF13B | R189G | Immunodeficiency, common variable, 2 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843844
- GRCh38:
- Chr17:16940530
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Likely benign (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875387
- GRCh38:
- Chr17:16972073
| TNFRSF13B | M1I | Immunodeficiency, common variable, 2 | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843094
- GRCh38:
- Chr17:16939780
| TNFRSF13B | G217S | Immunodeficiency, common variable, 2 | Uncertain significance (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852198-16852199
- GRCh38:
- Chr17:16948884-16948885
| TNFRSF13B | C100fs | Immunodeficiency, common variable, 2 | Pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875328
- GRCh38:
- Chr17:16972014
| TNFRSF13B | | Immunodeficiency, common variable, 2, Immunoglobulin A deficiency 2, Immunodeficiency, common variable, 2
| Pathogenic/Likely pathogenic (Aug 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:16852066
- GRCh38:
- Chr17:16948752
| TNFRSF13B | S144L | Immunodeficiency, common variable, 2 | Uncertain significance (Sep 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855827
- GRCh38:
- Chr17:16952513
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875309-16875389
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Uncertain significance (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852222
- GRCh38:
- Chr17:16948908
| TNFRSF13B | I92N | Immunodeficiency, common variable, 2 | Uncertain significance (Aug 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843687
- GRCh38:
- Chr17:16940373
| TNFRSF13B | C195F | Immunodeficiency, common variable, 2 | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16855838
- GRCh38:
- Chr17:16952524
| TNFRSF13B | D41H | Immunodeficiency, common variable, 2 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16875327
- GRCh38:
- Chr17:16972013
| TNFRSF13B | | Immunodeficiency, common variable, 2 | Pathogenic (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16852271
- GRCh38:
- Chr17:16948957
| TNFRSF13B | G76C | Immunodeficiency, common variable, 2 | Uncertain significance (Mar 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:16843104
- GRCh38:
- Chr17:16939790
| TNFRSF13B | M214fs | Immunodeficiency, common variable, 2 | Uncertain significance (Jan 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28947872
- GRCh38:
- Chr16:28936551
| CD19 | Q256H, Q345H | Immunodeficiency, common variable, 3, Immunodeficiency, common variable, 2, not provided
| Uncertain significance (Aug 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:16852140
- GRCh38:
- Chr17:16948826
| TNFRSF13B | R119S | Immunodeficiency, common variable, 2 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |